Dermapharm Holding SE Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 27, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	2,159	2,094	2,280	2,020	4,808	3,067
Market Cap Growth	2.95%	-8.13%	12.85%	-57.98%	56.78%	43.30%
Enterprise Value	3,020	3,007	3,258	2,493	5,294	3,584
Last Close Price	40.10	37.85	-	-	-	-
PE Ratio	18.61	18.41	36.55	15.05	22.94	35.73
PS Ratio	1.84	1.75	1.98	1.94	5.01	3.79
PB Ratio	3.34	3.44	4.18	3.79	9.62	9.45
P/TBV Ratio	-	-	-	41.96	310.95	-
P/FCF Ratio	13.13	12.84	12.82	8.10	25.42	33.96
P/OCF Ratio	10.45	10.40	10.39	7.00	19.20	23.39
EV/Sales Ratio	2.57	2.52	2.83	2.40	5.51	4.43
EV/EBITDA Ratio	11.42	11.99	14.79	8.24	16.95	23.12
EV/EBIT Ratio	13.08	13.54	16.87	8.82	17.89	25.58
EV/FCF Ratio	18.37	18.43	18.31	9.99	27.98	39.69
Debt / Equity Ratio	1.56	1.63	2.01	0.97	1.16	1.87
Debt / EBITDA Ratio	3.84	3.85	4.83	1.69	1.83	3.81
Debt / FCF Ratio	6.15	6.07	6.15	2.07	3.07	6.72
Net Debt / Equity Ratio	1.34	1.43	1.71	0.68	0.84	1.49
Net Debt / EBITDA Ratio	3.36	3.46	4.24	1.20	1.34	3.12
Net Debt / FCF Ratio	5.26	5.32	5.25	1.46	2.21	5.36
Asset Turnover	0.55	0.56	0.64	0.74	0.73	0.71
Inventory Turnover	1.22	1.34	1.55	1.57	1.56	1.86
Quick Ratio	0.95	0.72	0.75	1.18	1.61	1.39
Current Ratio	2.20	1.82	1.60	2.45	3.34	3.01
Return on Equity (ROE)	18.50%	19.38%	11.24%	25.69%	50.68%	28.21%
Return on Assets (ROA)	6.77%	6.55%	6.76%	12.53%	14.06%	7.72%
Return on Invested Capital (ROIC)	10.31%	9.76%	9.29%	19.12%	24.46%	12.55%
Return on Capital Employed (ROCE)	12.60%	12.70%	10.90%	23.70%	23.60%	12.80%
Earnings Yield	5.37%	5.43%	2.74%	6.64%	4.36%	2.80%
FCF Yield	7.61%	7.79%	7.80%	12.35%	3.93%	2.94%
Dividend Yield	2.32%	2.38%	-	-	-	-
Payout Ratio	41.76%	41.64%	90.64%	87.04%	22.61%	50.19%
Buyback Yield / Dilution	0.14%	-	-	-	-	-
Total Shareholder Return	2.46%	2.38%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.